Is Medpace Holdings, Inc. (MEDP) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.9% / 30% | 3.7% / 30% | 3.0% / 30% | 0.21% / 5% | ✓ HALAL |
| DJIM | 0.9% / 33% | 3.7% / 33% | 3.0% / 33% | 0.21% / 5% | ✓ HALAL |
| MSCI | 5.8% / 33% | 25.2% / 33% | 20.4% / 33% | 0.21% / 5% | ✓ HALAL |
| S&P | 0.9% / 33% | 3.7% / 33% | 3.0% / 33% | 0.21% / 5% | ✓ HALAL |
| FTSE | 5.8% / 33% | 25.2% / 33% | 20.4% / 50% | 0.21% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 71.1% | |
| Operating Margin | 21.6% | |
| Net Margin | 17.8% | |
| Return on Equity (ROE) | 70.2% | |
| Return on Assets (ROA) | 16.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $713M |
| Free Cash Flow | $682M |
| Total Debt | $114M |
| Debt-to-Equity | 29.8 |
| Current Ratio | 0.7 |
| Total Assets | $2.0B |
Price & Trading
| Last Close | $466.60 |
| 50-Day MA | $497.88 |
| 200-Day MA | $492.73 |
| Avg Volume | 334K |
| Beta | 1.5 |
|
52-Week Range
$250.05
| |
About Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Purification Calculator
As a halal stock with 0.21% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Medpace Holdings, Inc. (MEDP) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Medpace Holdings, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Medpace Holdings, Inc.'s debt ratio?
Medpace Holdings, Inc.'s debt ratio is 0.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 5.8%.
Does Medpace Holdings, Inc. require dividend purification?
Yes, Medpace Holdings, Inc. has an impermissible income ratio of 0.21%, which means 0.21% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Medpace Holdings, Inc.'s key financial metrics?
Medpace Holdings, Inc. has a market capitalization of $12.8B, trailing P/E ratio of 29.5, and revenue of $2.5B. The company maintains a gross margin of 71.1% and a net margin of 17.8%. Return on equity stands at 70.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.